LEADER 04582nam 2200709 a 450 001 9910972253203321 005 20251017110121.0 010 $a9786613213358 010 $a9780309225052 010 $a0309225051 010 $a9781283213356 010 $a1283213354 010 $a9780309162982 010 $a030916298X 035 $a(CKB)2550000000043071 035 $a(EBL)3378796 035 $a(SSID)ssj0000539524 035 $a(PQKBManifestationID)11324607 035 $a(PQKBTitleCode)TC0000539524 035 $a(PQKBWorkID)10570807 035 $a(PQKB)11319470 035 $a(MiAaPQ)EBC3378796 035 $a(Au-PeEL)EBL3378796 035 $a(CaPaEBR)ebr10488616 035 $a(CaONFJC)MIL321335 035 $a(OCoLC)923283602 035 $a(Perlego)4739880 035 $a(DNLM)1568300 035 $a(EXLCZ)992550000000043071 100 $a20110827d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe new profile of drug-resistant tuberculosis in Russia $ea global and local perspective : summary of a joing workshop by the Institute of Medicine and the Russian Academy of Medical Science /$fInstitute of Medicine of the National Academies and Russian Academy of Medical Sciences 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$d2011 215 $a1 online resource (150 p.) 300 $a"Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy. 311 08$a9780309162975 311 08$a0309162971 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 A Global Perspective on Drug-Resistant Tuberculosis""; ""3 Drug-Resistant Tuberculosis in the Russian Federation""; ""4 Transmission and Infection Control of Drug-Resistant TB""; ""5 Diagnosis of Drug-Resistant TB""; ""6 Treatment of Drug-Resistant TB""; ""7 TB and Drug-Resistant TB in Vulnerable Populations""; ""8 The Second-Line Drug Supply Chain""; ""9 The Development of New TB Diagnostics and Drugs""; ""10 Convergence of Science and Policy to Create a Call for Action"" 327 $a""References""""Appendix A: Agenda""; ""Appendix B: Summary of a Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Held May 24-25, 2010, Moscow, Russian Federation""; ""Appendix C: Participant Biographies"" 330 $aAn estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options. 606 $aTuberculosis$zRussia 615 0$aTuberculosis 676 $a614.409542 701 $aOlsen$b Steve$01807544 701 $aEnglish$b Rebecca$01807545 701 $aClaiborne$b Anne$01807546 712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation. 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy. 712 02$aRossiiskaia akademiia meditsinskikh nauk. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910972253203321 996 $aThe new profile of drug-resistant tuberculosis in Russia$94357330 997 $aUNINA